Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Up 23.8% in December

Avalo Therapeutics, Inc. (NASDAQ:AVTX – Get Free Report) was the recipient of a large growth in short interest in December. As of December 15th, there was short interest totalling 12,640,000 shares, a growth of 23.8% from the November 30th total of 10,210,000 shares. Based on an average trading volume of 51,393,300 shares, the short-interest ratio […]

Related Keywords

,Vr Adviser ,Nasdaq ,Avalo Therapeutics Company Profile ,Acadian Asset Management ,Susquehanna International Group ,Avalo Therapeutics Inc ,Goldman Sachs Group Inc ,Avalo Therapeutics ,Get Free Report ,Therapeutics Stock Down ,International Group ,Sachs Group ,Avalo Therapeutics Daily ,Nasdaq Avtx ,Avtx ,Medical ,Stocks ,Options ,Put ,Call ,